FAKTOR OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000GQ6BS82

Real-time BOERSE MUENCHEN 09:56:47 21/06/2024 pm IST
7.72 EUR -9.71% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month-3.06%
1 month+23.55%
Date Price Change
21/24/21 7.72 -9.71%
20/24/20 8.55 -33.31%
19/24/19 12.82 +12.16%
18/24/18 11.43 +11.73%
17/24/17 10.23 +6.67%

Real-time BOERSE MUENCHEN

Last update June 21, 2024 at 09:56 pm IST

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GQ6BS8
ISINDE000GQ6BS82
Date issued 28/09/2023
Strike 318.6 $
Maturity Unlimited
Parity 2.66 : 1
Emission price 9.08
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 63.03
Lowest since issue 2.48
Spread 0.15
Spread %1.91%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.4 USD
Average target price
372.9 USD
Spread / Average Target
+9.25%
Consensus